Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Pulmonary Hypertension

  Free Subscription


1 Am J Physiol Heart Circ Physiol
3 Am J Physiol Lung Cell Mol Physiol
1 Ann Rheum Dis
1 Ann Thorac Surg
1 Card Fail Rev
1 Circ Cardiovasc Qual Outcomes
1 Circulation
1 Eur Clin Respir J
1 Eur Heart J Cardiovasc Imaging
1 Eur Respir J
1 Front Med (Lausanne)
1 Int J Mol Sci
1 J Clin Imaging Sci
1 J Heart Lung Transplant
1 J Perinatol
1 J Thorac Cardiovasc Surg
1 JACC Basic Transl Sci
1 Life Sci
1 Lung
1 PLoS One
2 Pol Arch Intern Med
1 Postepy Kardiol Interwencyjnej
1 Rev Esp Cardiol (Engl Ed)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Physiol Heart Circ Physiol

  1. FRANK BS, Schafer M, Douwes JM, Ivy DD, et al
    Novel measures of left ventricular electromechanical discoordination predict clinical outcomes in children with pulmonary arterial hypertension.
    Am J Physiol Heart Circ Physiol. 2020;318:H401-H412.
    PubMed         Abstract available

    Am J Physiol Lung Cell Mol Physiol

  2. BABICHEVA A, Ayon RJ, Zhao T, Ek Vitorin JF, et al
    MicroRNA-mediated downregulation of K(+) channels in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L10-L26.
    PubMed         Abstract available

  3. NORVIK C, Westoo CK, Peruzzi N, Lovric G, et al
    Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L65-L75.
    PubMed         Abstract available

  4. ELINOFF JM, Mazer AJ, Cai R, Lu M, et al
    Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2020;318:L98-L111.
    PubMed         Abstract available

    Ann Rheum Dis

  5. XANTHOULI P, Jordan S, Milde N, Marra A, et al
    Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Ann Rheum Dis. 2020;79:370-378.
    PubMed         Abstract available

    Ann Thorac Surg

  6. ODA H, Hamaji M, Motoyama H, Ikeda T, et al
    Use of a three-dimensional model in lung transplantation for a patient with giant pulmonary aneurysm.
    Ann Thorac Surg. 2019 Aug 22. pii: S0003-4975(19)31213.
    PubMed         Abstract available

    Card Fail Rev

  7. RAO SD, Adusumalli S, Mazurek JA
    Pulmonary Hypertension in Heart Failure Patients.
    Card Fail Rev. 2020;6:e05.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  8. PIGHI M, Piazza N, Martucci G, Lachapelle K, et al
    Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.
    Circ Cardiovasc Qual Outcomes. 2019;12:e005363.
    PubMed         Abstract available


  9. HOFFMANN F, Limper U, Zaha VG, Reuter H, et al
    Evolution of Pulmonary Hypertension During Severe Sustained Hypoxia.
    Circulation. 2020;141:1504-1506.

    Eur Clin Respir J

  10. FARKHOOY A, Bellocchia M, Hedenstrom H, Libertucci D, et al
    Lung function in relation to six-minute walk test in pulmonary hypertension.
    Eur Clin Respir J. 2020;7:1745492.
    PubMed         Abstract available

    Eur Heart J Cardiovasc Imaging

  11. YAMASAKI Y, Abe K, Kamitani T, Hosokawa K, et al
    Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2020 May 1. pii: 5827720.
    PubMed         Abstract available

    Eur Respir J

  12. SITBON O, Reis A, Humbert M, Vonk Noordegraaf A, et al
    Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration.
    Eur Respir J. 2020;55.

    Front Med (Lausanne)

  13. THOMPSON AAR, Wilkins MR, Wild JM, Kiely DG, et al
    Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future.
    Front Med (Lausanne). 2020;7:125.

    Int J Mol Sci

  14. CARREGAL-ROMERO S, Fadon L, Berra E, Ruiz-Cabello J, et al
    MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

    J Clin Imaging Sci

  15. PO JR, Tong M, Meeran T, Potluri A, et al
    Quantification of Cardiac Output with Phase Contrast Magnetic Resonance Imaging in Patients with Pulmonary Hypertension.
    J Clin Imaging Sci. 2020;10:26.
    PubMed         Abstract available

    J Heart Lung Transplant

  16. KWON JM, Kim KH, Medina-Inojosa J, Jeon KH, et al
    Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.
    J Heart Lung Transplant. 2020 Apr 23. pii: S1053-2498(20)31516.
    PubMed         Abstract available

    J Perinatol

  17. GRIFFITHS M, Yang J, Everett AD, Jennings JM, et al
    Endostatin and ST2 are predictors of pulmonary hypertension disease course in infants.
    J Perinatol. 2020 May 4. pii: 10.1038/s41372-020-0671.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  18. MIAO H, Qiu F, Zhu L, Jiang B, et al
    Novel angiogenesis strategy to ameliorate pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30710.
    PubMed         Abstract available

    JACC Basic Transl Sci

  19. GARCIA-LUNAR I, Blanco I, Fernandez-Friera L, Prat-Gonzalez S, et al
    Design of the beta3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.
    JACC Basic Transl Sci. 2020;5:317-327.
    PubMed         Abstract available

    Life Sci

  20. ULLOA NA, Cook J, Cao YY, Ba HX, et al
    Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Life Sci. 2020;250:117548.
    PubMed         Abstract available


  21. SCHOENBERG NC, Argula RG, Klings ES, Wilson KC, et al
    Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis.
    Lung. 2020 May 4. pii: 10.1007/s00408-020-00355.
    PubMed         Abstract available

    PLoS One

  22. CONNOLLY M, Garfield BE, Crosby A, Morrell NW, et al
    miR-1-5p targets TGF-betaR1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension.
    PLoS One. 2020;15:e0229409.
    PubMed         Abstract available

    Pol Arch Intern Med

    Pulmonary arterial hypertension and pulmonary hypertension due to left heart disease: so near and yet so far.
    Pol Arch Intern Med. 2020;130:349-350.

  24. JONAS K, Kopec G
    Pulmonary arterial hypertension and pulmonary hypertension due to left heart disease: so near and yet so far. Authors' reply.
    Pol Arch Intern Med. 2020;130:350-351.

    Postepy Kardiol Interwencyjnej

  25. GEBKA A, Rajtar-Salwa R, Dziewierz A, Petkow-Dimitrow P, et al
    Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy.
    Postepy Kardiol Interwencyjnej. 2020;16:97-101.
    PubMed         Abstract available

    Rev Esp Cardiol (Engl Ed)

  26. DE FRUTOS F, Diez-Lopez C, Sanchez-Salado JC, Miralles A, et al
    Left ventricular assist devices in patients eligible for heart transplant with irreversible pulmonary hypertension.
    Rev Esp Cardiol (Engl Ed). 2020 May 3. pii: S1885-5857(20)30115.

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.